Results 221 to 230 of about 2,310,068 (246)

Novel Treatment Strategy for Patients With Urea Cycle Disorders: Pharmacological Chaperones Enhance Enzyme Stability and Activity in Patient-Derived Liver Disease Models. [PDF]

open access: yesJ Inherit Metab Dis
Ramosaj A   +15 more
europepmc   +1 more source

Mapping challenges in the accessibility of treatment products for urea cycle disorders: A survey of European healthcare professionals. [PDF]

open access: yesJ Inherit Metab Dis
Stolwijk NN   +6 more
europepmc   +1 more source

Hierarchical Tricarboxylic Acid Cycle Regulation by Hepatocyte Arginase 2 Links the Urea Cycle to Oxidative Metabolism [PDF]

open access: yesCell Metabolism
Urea cycle impairment and its relationship to obesity and inflammation remained elusive, partly due to the dramatic clinical presentation of classical urea cycle defects.
Yiming Zhang   +2 more
exaly   +2 more sources

The Incidence of Urea Cycle Disorders

open access: yesMolecular Genetics and Metabolism, 2013
A key question for urea cycle disorders is their incidence. In the United States two UCDs, argininosuccinic synthetase and lyase deficiency, are currently detected by newborn screening. We used newborn screening data on over 6million births and data from
Stefan Kolker   +2 more
exaly   +2 more sources

A Longitudinal Study of Urea Cycle Disorders

open access: yesMolecular Genetics and Metabolism, 2014
The Urea Cycle Disorders Consortium (UCDC) is a member of the NIH funded Rare Diseases Clinical Research Network and is performing a longitudinal study of 8 urea cycle disorders (UCDs) with initial enrollment beginning in 2006. The consortium consists of
Mark L Batshaw   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy